CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 71442-71576 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T598","span":{"begin":0,"end":134},"obj":"Sentence"},{"id":"T69368","span":{"begin":0,"end":134},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Finally, the efficacy of antibiotics in development will be presented again focusing on the MRSA subgroups from phase 2 and 3 studies."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T156","span":{"begin":0,"end":134},"obj":"Sentence"}],"text":"Finally, the efficacy of antibiotics in development will be presented again focusing on the MRSA subgroups from phase 2 and 3 studies."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T248","span":{"begin":92,"end":96},"obj":"Disease"},{"id":"T97622","span":{"begin":92,"end":96},"obj":"Disease"}],"attributes":[{"id":"A248","pred":"mondo_id","subj":"T248","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A67998","pred":"mondo_id","subj":"T97622","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"}],"text":"Finally, the efficacy of antibiotics in development will be presented again focusing on the MRSA subgroups from phase 2 and 3 studies."}